These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12466322)

  • 1. The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors.
    Koch CA; Pacak K; Chrousos GP
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5367-84. PubMed ID: 12466322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular pathogenesis of childhood adrenocortical tumors.
    Almeida MQ; Latronico AC
    Horm Metab Res; 2007 Jun; 39(6):461-6. PubMed ID: 17578765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the role of genetic alterations in adrenocortical tumorigenesis.
    Herbet M; Feige JJ; Thomas M
    Mol Cell Endocrinol; 2009 Mar; 300(1-2):169-74. PubMed ID: 19007854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of adrenal tumors.
    Opocher G; Schiavi F; Cicala MV; Patalano A; Mariniello B; Boaretto F; Zovato S; Pignataro V; Macino B; Negro I; Mantero F
    Minerva Endocrinol; 2009 Jun; 34(2):107-21. PubMed ID: 19471236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenocortical tumorigenesis.
    Beuschlein F; Reincke M
    Ann N Y Acad Sci; 2006 Nov; 1088():319-34. PubMed ID: 17192577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MEN1 gene analysis in sporadic adrenocortical neoplasms.
    Heppner C; Reincke M; Agarwal SK; Mora P; Allolio B; Burns AL; Spiegel AM; Marx SJ
    J Clin Endocrinol Metab; 1999 Jan; 84(1):216-9. PubMed ID: 9920087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent data in adrenocortical tumorigenesis].
    Crand A; Borson-Chazot F; Brue T
    Ann Endocrinol (Paris); 2009 Sep; 70 Suppl 1():S20-5. PubMed ID: 19878765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic guidelines for adrenal gland nodules: typing, assessment of biological potential and prognosis, molecular pathogenesis].
    Schröder S; Padberg B; Reincke M; Komminoth P
    Verh Dtsch Ges Pathol; 1997; 81():97-102. PubMed ID: 9474859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular biology of incidentally diagnosed adrenal gland space-occupying lesion].
    Reincke M; Allolio B
    Zentralbl Chir; 1997; 122(6):430-7. PubMed ID: 9334108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal cortical tumors and multiple endocrine neoplasia-related syndromes.
    Haase M; Willenberg HS
    Minerva Endocrinol; 2009 Jun; 34(2):123-35. PubMed ID: 19471237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas.
    Bertherat J; Gimenez-Roqueplo AP
    Horm Metab Res; 2005 Jun; 37(6):384-90. PubMed ID: 16001332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenocortical tumorigenesis in transgenic mice: the role of luteinizing hormone receptor and transcription factors GATA-4 and GATA-61.
    Rahman NA; Kiiveri S; Siltanen S; Levallet J; Kero J; Lensu T; Wilson DB; Heikinheimo MT; Huhtaniemi IT
    Reprod Biol; 2001 Jul; 1(1):5-9. PubMed ID: 14666170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
    Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphological typing, evaluation of tumor dignity and prognosis and etiologic classification of adrenomedullary and adrenocortical neoplasias].
    Schröder S; Komminoth P; Padberg B; Heitz PU
    Pathologe; 1995 Sep; 16(5):307-14. PubMed ID: 7479602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNAs in adrenal tumors.
    Igaz P
    Curr Opin Endocrinol Diabetes Obes; 2019 Jun; 26(3):155-159. PubMed ID: 30801265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular markers and the pathogenesis of adrenocortical cancer.
    Soon PS; McDonald KL; Robinson BG; Sidhu SB
    Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
    Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
    Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sporadic adrenocortical tumors: genetics and perspectives for the pathologist].
    Tissier F
    Ann Pathol; 2008 Oct; 28(5):409-16. PubMed ID: 19068395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenocortical growth and cancer.
    Lefèvre L; Bertherat J; Ragazzon B
    Compr Physiol; 2015 Jan; 5(1):293-326. PubMed ID: 25589272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular aspects of adrenal tumours.
    McNicol AM
    Minerva Endocrinol; 1995 Mar; 20(1):9-13. PubMed ID: 7651288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.